RT @laura_rottner: Heute schlagen Frauenherzen höher! 🫀🙋‍♀️🆙 #GoRedDay 🚨Vorhofflimmern ist auch bei Frauen die häufigste Herzrhythmusstö…

RT @JBauersachsMD: 🔥 just published in #EHJ: The year in cardiovascular medicine 2024: the top 10 papers in #heartfailure ⁦@ShelleyZierot…

RT @NEJM: @COREIMpodcast Read the full REVISE trial results published in NEJM:

Defining a New “Mayo Stage IIIc” Ultra Poor Risk Category in Systemic ...

International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update | JACC: Cardiovascular Interventions

RT @ACNAPPresident: #Cardiomyopathies #ACNAPTopicOfTheMonth Patients with a cardiomyopathy require the collaboration of different specialt…

RT @vass_vassiliou: Really pleased that this negative trial was published @nejm Spironolactone post MI had absolutely no benefit https://…

@vass_vassiliou @NEJM @mmamas1973 @DrMarthaGulati @HanCardiomd @Hragy @purviparwani @anast_apost @AnastasiaSMihai @AnnaGiuliaPavon @AnnaKateBarton Well said!

RT @AHAScience: Nex-z results presented at #AHA24 In patients w/ ATTR-CM, the CRISPR-based therapy nexiguran ziclumeran (nex-z) reduced s…

RT @purviparwani: “Lobster Claw sign” on #Echofirst Generally seen on #ApicalHCM ( clearly too many HCM cases in two days 🤓) 🍩 Blood tra…

RT @VikashJaiswalMD: The use of SGLT2i is associated with a significant reduction in the risk of 1: All-cause mortality ☠️ 2: Major advers…

RT @escardio: .@Drroxmehran highlights key takeaways from the OPTION trial #ESCTVOntheRoad #AHA24

RT @Ron_Witteles: Another day, another #ATTR amyloidosis trial published in @NEJM! Exciting late-breaker @American_Heart #AHA24, looking at…

RT @JAMACardio: Small mean treatment effects in heart failure trials may still lead to clinically meaningful improvements for a significant…

RT @hmkyale: 1/ 🧑‍⚕️ Sitting too long? It could harm your heart. A new @JACCJournals study analyzed nearly 90,000 people & found 10.6+ hour…

@SHEIN_Official Huge Congratulations and good luck!

RT @CircAHA: In an RCT of patients with hypertrophic cardiomyopathy without obstruction, a 12-week (3h/week) supervised exercise program re…

RT @Herzmedizin_de: Der #Bundestag hat den Entwurf des #GesundesHerzGesetz (#GHG) in erster Lesung beraten. Ziel: kardiovaskuläre Risiken f…

RT @JAMACardio: In patients with severe secondary tricuspid regurgitation, this study found a high prevalence of concomitant heart failure…

RT @JJheart_doc: Alright #MedTwitter, here's some 🔥 data on optimizing #GDMT for #heartfailure and highlight the recent work of @AferditaMD…